Related Experiment Video
Updated: May 31, 2026
12:34
The Efficacy and Underlying Pathway Mechanisms of ShiDuGao Treatment for Anus Eczema Based on GEO Datasets and Network Pharmacology
Published on: January 12, 2024
Eczema Action Plans: Do They Improve Objective Disease Outcomes?
Priya Kadu1, Chenan Huang1, Matthew Zirwas2
1Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Clinical and Experimental Dermatology
|May 29, 2026
Summary
Eczema action plans did not improve disease severity or quality of life in patients with eczema. While improving patient knowledge and confidence, complex plans may hinder adherence and clinical outcomes.
Area of Science:
- Dermatology
- Clinical Trials
- Patient Management
Background:
- Eczema action plans are increasingly used as a patient management tool.
- Previous research explored their impact on quality of life and disease severity.
- The effectiveness of these plans in improving eczema outcomes requires further examination.
Purpose of the Study:
- To evaluate the effectiveness of eczema action plans in managing eczema.
- To synthesize evidence from clinical trials on eczema action plan efficacy.
Main Methods:
- A systematic literature search was performed across MEDLINE, EMBASE, and SCOPUS.
- Included studies were clinical trials assessing eczema action plans for eczema management.
- Five studies (four randomized controlled trials, one non-randomized trial) were analyzed.
Main Results:
- Eczema action plans did not demonstrate objective improvements in atopic dermatitis severity.
- No significant enhancement in patients' quality of life was observed.
- Patient knowledge, confidence, and satisfaction increased, but did not correlate with clinical benefits.
Conclusions:
- Eczema action plans may not directly improve clinical outcomes like disease severity or quality of life.
- Enhanced patient understanding and confidence did not translate into measurable clinical benefits.
- Complex treatment regimens within action plans might impede patient adherence, limiting effectiveness.
Related Concept Videos
01:27Acne Infection
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
01:19Clinical Applications of Epidermal Stem Cells
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own EpiSCs...
01:30Asthma-IV: Nursing Management
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
01:11Guidelines for Writing Outcome
When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...